A Randomized, Double-Blind, Placebo-Controlled With Active Comparator, 12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin
Phase of Trial: Phase II
Latest Information Update: 14 Aug 2017
At a glance
- Drugs DS-8500 (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Inc
- 10 Jun 2017 Biomarkers information updated
- 20 Mar 2017 Status changed from active, no longer recruiting to completed.
- 26 Sep 2016 Status changed from recruiting to active, no longer recruiting.